|Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases|
Y Fong, J Fortner, RL Sun, MF Brennan, LH Blumgart
Annals of surgery 230 (3), 309, 1999
|Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia|
KJ Tracey, Y Fong, DG Hesse, KR Manogue, AT Lee, GC Kuo, SF Lowry, ...
Nature 330 (6149), 662-664, 1987
|Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade|
WR Jarnagin, M Gonen, Y Fong, RP DeMatteo, L Ben-Porat, S Little, ...
Annals of surgery 236 (4), 397, 2002
|Liver resection for colorectal metastases.|
Y Fong, AM Cohen, JG Fortner, WE Enker, AD Turnbull, DG Coit, ...
Journal of Clinical Oncology 15 (3), 938-946, 1997
|Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma|
WR Jarnagin, Y Fong, RP DeMatteo, M Gonen, EC Burke, J Bodniewicz, ...
Annals of surgery 234 (4), 507, 2001
|The international position on laparoscopic liver surgery: The Louisville Statement, 2008|
JF Buell, D Cherqui, DA Geller, N O’Rourke, D Iannitti, I Dagher, ...
Annals of surgery 250 (5), 825-830, 2009
|Actual 10-year survival after resection of colorectal liver metastases defines cure|
JS Tomlinson, WR Jarnagin, RP DeMatteo, Y Fong, P Kornprat, M Gonen, ...
Journal of Clinical Oncology 25 (29), 4575-4580, 2007
|Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer|
N Kemeny, Y Huang, AM Cohen, W Shi, JA Conti, MF Brennan, ...
New England Journal of Medicine 341 (27), 2039-2048, 1999
|An analysis of 412 cases of hepatocellular carcinoma at a Western center|
Y Fong, RL Sun, W Jarnagin, LH Blumgart
Annals of surgery 229 (6), 790, 1999
|Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.|
KJ Tracey, HE Wei, KR Manogue, Y Fong, DG Hesse, HT Nguyen, ...
The Journal of experimental medicine 167 (3), 1211-1227, 1988
|Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.|
Y Fong, KJ Tracey, LL Moldawer, DG Hesse, KB Manogue, JS Kenney, ...
The Journal of experimental medicine 170 (5), 1627-1633, 1989
|Cytokine appearance in human endotoxemia and primate bacteremia.|
DG Hesse, KJ Tracey, Y Fong, KR Manogue, MA Palladino Jr, A Cerami, ...
Surgery, gynecology & obstetrics 166 (2), 147-153, 1988
|Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection|
I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou, D Klimstra, M D'Angelica, ...
Annals of surgery 248 (1), 84-96, 2008
|Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog|
KJ Tracey, SF Lowry, TJ Fahey, JD Albert, Y Fong, D Hesse, B Beutler, ...
Surgery Gynecology and Obstetrics 164 (5), 415-422, 1987
|Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases|
DA Kooby, J Stockman, L Ben-Porat, M Gonen, WR Jarnagin, ...
Annals of surgery 237 (6), 860, 2003
|Hepatic neuroendocrine metastases: does intervention alter outcomes?|
RS Chamberlain, D Canes, KT Brown, L Saltz, W Jarnagin, Y Fong, ...
Journal of the American College of Surgeons 190 (4), 432-445, 2000
|Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.|
EC Burke, WR Jarnagin, SN Hochwald, PW Pisters, Y Fong, LH Blumgart
Annals of surgery 228 (3), 385, 1998
|Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction|
JA Melendez, V Arslan, ME Fischer, D Wuest, WR Jarnagin, Y Fong, ...
Journal of the American College of Surgeons 187 (6), 620-625, 1998
|Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients.|
Y Fong, DG Coit, JM Woodruff, MF Brennan
Annals of surgery 217 (1), 72, 1993
|Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis|
MY Fong, W Zhou, L Liu, AY Alontaga, M Chandra, J Ashby, A Chow, ...
Nature cell biology 17 (2), 183-194, 2015